Artificial Pancreas Comes to Market

MiniMed 670G is a new wearable device that uses A.I. to measure glucose levels and deliver precise amounts of insulin.

MiniMed 670G System / Image: Medtronic
MiniMed 670G System / Image: Medtronic

A May 2nd USA Today article contained good news for the 30 million Americans affected by diabetes. A new artificial pancreas is here to replace lancets, test strips and syringes. The MiniMed 670G is a closed loop hybrid system from Medtronic that continually self-adjusts to manage sugar levels based on the activity of its wearer, similar to how a Nest thermostat manages the climate in your home.

The device is only intended for type 1 diabetics whose pancreases produce little or no insulin. The device features a color screen that’s readable day or night, and it’s waterproof so it can be worn during underwater activities like swimming or snorkeling. The device was approved by the FDA in September of 2016, and is available now.

Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report